Sales reported at Rs 3.27 crore
Net profit of Beryl Drugs rose 188.24% to Rs 0.49 crore in the quarter ended September 2020 as against Rs 0.17 crore during the previous quarter ended September 2019. Sales remain constant at Rs 3.27 crore in the quarter ended September 2020 and also during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales3.273.27 0 OPM %28.1310.70 -PBDT0.830.33 152 PBT0.480.23 109 NP0.490.17 188Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
